ICH Q9 established a framework for QRM with the intention of introducing QRM approaches that could be leveraged by both the industry and regulators. However, it has been observed that the full potential of QRM has not been reached, which is the reason why the council decided on issuing a revision. The new themes serve as areas of improvement that can facilitate the implementation of QRM.
In this webinar we will highlight the key principles of the guideline, investigate the core QRM process and focus on the updates of this latest revision (R1)
Dr. Ulrich Koellisch has been on the forefront of the data integrity initiatives and in his previous eight years. He has supported many organizations in the pharmaceutical and biotech sector executing Data Integrity campaigns. Ulrich has...
Dr. Thaleia Papadopoulou is conducting Data Integrity assessments in the Life Science industry within the area of GMP Manufacturing, supports clients with setting up Quality Management Systems and performing Risk Assessments and has been...
James Francum is a seasoned Life Science Compliance expert with 20+ years as GxP-CC CEO. Specializing in FDA, EMA & ANVISA, he's worked in 27+ countries with global Life Sciences Industry players. An MBA holder, he's an active member of related...